Hologic Timeline

History of Innovation

Scroll to learn more
1985

FDA clears the first nucleic acid test.

1985

FDA clears the first nucleic acid test.

1987

Hologic introduces the first dual-energy X-ray absorptiometry system for evaluating osteoporosis.

1987

Hologic introduces the first dual-energy X-ray absorptiometry system for evaluating osteoporosis.

1988

FDA clears the first molecular diagnostic test kit for a sexually transmitted infection.

1988

FDA clears the first molecular diagnostic test kit for a sexually transmitted infection.

1995

FDA approves the Rapid fFN® test.

1995

FDA approves the Rapid fFN® test.

1996

FDA approves the ThinPrep® Pap test, liquid-based cytology for cervical cancer screening.

1996

FDA approves the ThinPrep® Pap test, liquid-based cytology for cervical cancer screening.

2001

FDA approves the NovaSure® endometrial ablation treatment for abnormal uterine bleeding (AUB).

2001

FDA approves the NovaSure® endometrial ablation treatment for abnormal uterine bleeding (AUB).

2002

FDA approves the Selenia® mammography system–the beginning of a new era in breast cancer screening.

2002

FDA approves the Selenia® mammography system–the beginning of a new era in breast cancer screening.

2002

FDA approves the first nucleic acid test for screening donated blood prior to transfusion.  

*Procleix and Ultrio are registered trademarks of Grifols, SA.

2002

FDA approves the first nucleic acid test for screening donated blood prior to transfusion.  

*Procleix and Ultrio are registered trademarks of Grifols, SA.

2003

Release of the Tigris® DTS® system for automated screening of sexually transmitted infections (STIs).

2003

Release of the Tigris® DTS® system for automated screening of sexually transmitted infections (STIs).

2004

FDA clears Elite™, the first dual-wavelength system—two lasers in one workstation—allowing multiple applications across skin types.

2004

FDA clears Elite™, the first dual-wavelength system—two lasers in one workstation—allowing multiple applications across skin types.

2005

FDA clears Cynergy™, the first dual-wavelength vascular system with MultiPlex™ technology—two wavelengths firing sequentially.

2005

FDA clears Cynergy™, the first dual-wavelength vascular system with MultiPlex™ technology—two wavelengths firing sequentially.

2006

FDA clears Smartlipo®, the first minimally invasive laser-lipolysis system, revolutionizing the body contouring market.

2006

FDA clears Smartlipo®, the first minimally invasive laser-lipolysis system, revolutionizing the body contouring market.

2008

FDA approves the Procleix® Ultrio®* triplex blood screening assay for HIV-1, hepatitis B and C.

*Procleix and Ultrio are registered trademarks of Grifols, SA.
 

2008

FDA approves the Procleix® Ultrio®* triplex blood screening assay for HIV-1, hepatitis B and C.

*Procleix and Ultrio are registered trademarks of Grifols, SA.
 

2011

FDA approves the breakthrough Selenia Dimensions® digital tomosynthesis system with the Hologic 3D Mammography™ exam.

2011

FDA approves the breakthrough Selenia Dimensions® digital tomosynthesis system with the Hologic 3D Mammography™ exam.

2011

Release of the Icon™ aesthetic system, the first all-in-one platform with the Skintel® Melanin Reader™ offering a wide variety of aesthetic treatments with enhanced safety and efficacy.

2011

Release of the Icon™ aesthetic system, the first all-in-one platform with the Skintel® Melanin Reader™ offering a wide variety of aesthetic treatments with enhanced safety and efficacy.

2012

FDA clears the Panther® system, an automated, integrated molecular platform, for use with the Aptima Combo 2® assay.

2012

FDA clears the Panther® system, an automated, integrated molecular platform, for use with the Aptima Combo 2® assay.

2012

FDA clears PicoSure®, the world’s first aesthetic picosecond laser, which revolutionized skin revitalization and tattoo removal.

2012

FDA clears PicoSure®, the world’s first aesthetic picosecond laser, which revolutionized skin revitalization and tattoo removal.

2014

FDA clears the use of the bone densitometer for assessing three critical health problems, including osteoporosis

2014

FDA clears the use of the bone densitometer for assessing three critical health problems, including osteoporosis

2014

FDA clears the DEKA SmartXide Laser System, MonaLisa Touch® therapy, an innovative CO2 laser for gynecologic use.

2014

FDA clears the DEKA SmartXide Laser System, MonaLisa Touch® therapy, an innovative CO2 laser for gynecologic use.

2015

CE marked virology portfolio, including Aptima® HIV, HCV and HBV assays, along with the Aptima® M. genitalium assay.

2015

CE marked virology portfolio, including Aptima® HIV, HCV and HBV assays, along with the Aptima® M. genitalium assay.

2015

FDA clears the SculpSure® device, the first non-invasive laser treatment for reducing unwanted fat.

2015

FDA clears the SculpSure® device, the first non-invasive laser treatment for reducing unwanted fat.

2016

FDA clears the new Affirm® prone biopsy system.

2016

FDA clears the new Affirm® prone biopsy system.

2017

The Brevera® breast biopsy system with CorLumina® imaging technology combines tissue acquisition, real-time imaging, verification and advanced tissue handling.

2017

The Brevera® breast biopsy system with CorLumina® imaging technology combines tissue acquisition, real-time imaging, verification and advanced tissue handling.

2017

FDA approves Aptima® HIV-1 Quant assay, Aptima® HCV Quant DX assay, and the Aptima® HSV 1 & 2 assay. The Panther Fusion® respiratory assays were approved on the Panther Fusion system.

2017

FDA approves Aptima® HIV-1 Quant assay, Aptima® HCV Quant DX assay, and the Aptima® HSV 1 & 2 assay. The Panther Fusion® respiratory assays were approved on the Panther Fusion system.

2018

FDA clears Clarity HD high-resolution 3D™ imaging and the SmartCurve™ breast stabilization system, providing superior image quality and a clinically proven solution for a more comfortable mammogram.

2018

FDA clears Clarity HD high-resolution 3D™ imaging and the SmartCurve™ breast stabilization system, providing superior image quality and a clinically proven solution for a more comfortable mammogram.

2018

FDA clears TempSure™, a new innovative radiofrequency aesthetic platform

2018

FDA clears TempSure™, a new innovative radiofrequency aesthetic platform